At a glance
- Originator Nonindustrial source
- Class Antiplatelets
- Mechanism of Action Cyclic AMP phosphodiesterase inhibitors; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders; Thrombosis
Most Recent Events
- 16 Nov 1998 New profile
- 16 Nov 1998 Preclinical development for Ischaemic heart disorders in Italy (Unknown route)
- 16 Nov 1998 Preclinical development for Thrombosis in Italy (Unknown route)